Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05770765

Creation of a Bank of Biological Materials and Associated Data Related to Patients With Infectious and Tropical Diseases

Status
Recruiting
Phase
Study type
Observational
Enrollment
60,000 (estimated)
Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is the protocol that formalizes the establishment of the TROPICA-BIOBANK biobank

Detailed description

Subjects who will access the Department of Infectious and Tropical Diseases for investigations, analyzes or visits on suspicion of infectious or tropical disease, hospitalized patients and/or patients participating in proposed clinical trials from the Department will be enrolled. Healthy volunteer donors may also be enrolled. The type of samples collected and stored in the biobank consists of human biological matrices liquids and solids, DNA, protein extracts or subcellular fractions, bacterial isolates and arthropods taken from patients. The collection of samples takes place through the support of various professional figures (doctor, nurse, laboratory technician, biologist/biotechnologist) together with associated data. The samples are de-identified and protected by an encryption system (through the system computer diagnostic data management of the laboratory of the IRCCS Sacro Cuore Don Calabria) and stored at a temperature of -80°C, in the Department's freezers. Samples are stored for 40 years. In order to monitor the quality of the samples over the storage time, a selection of samples used as monthly analytical quality controls will be retested periodically (every 10 years). At the end of the storage time, it will be evaluated whether to extend the storage time of the unused biological samples and associated data or if these will be destroyed. In the first case, an amendment to this Protocol will be submitted to the CESC for approval, in which will specify the duration of the extension of the conservation of the samples and associated data. In the second case, no further data will be collected on the aforementioned samples, without prejudice to their use of those possibly already collected to determine, without altering them, the results of searches already in progress. The samples will in any case be destroyed if they are not in good condition.

Conditions

Timeline

Start date
2019-10-30
Primary completion
2059-10-30
Completion
2059-10-30
First posted
2023-03-15
Last updated
2023-03-15

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05770765. Inclusion in this directory is not an endorsement.